top of page

Aspiring to Improve Patients' Lives

NEXT- GENERATION THERAPEUTICS FOR INFLAMMATORY DISEASES

NEXT- GENERATION THERAPEUTICS FOR INFLAMMATORY DISEASES

Aspiring to Improve Patients' Lives

Latest News

March 10, 2026

Results from Phase 3 Study of Rademikibart in Moderate-to-Severe Atopic Dermatitis to be Presented in the Late-Breaking Research Session at 2026 AAD Annual Meeting

March 3, 2026

Connect Biopharma to Present at the Leerink Partners Global Healthcare Conference

February 19, 2026

Connect Biopharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

See all press releases >>

bottom of page